Mild (n = 98) | Severe (n = 75) | Total (n = 173) | |
---|---|---|---|
Severity subgroup, n (%) | |||
Asymptomatic | 37 (37.8%) | 37 (21.4%) | |
Mild | 61 (62.2%) | 61 (35.3%) | |
Severe | 65 (86.7%) | 65 (37.6%) | |
Severe/Critical | 10 (13.30%) | 10 (5.80%) | |
Sex, n (%) | |||
Male | 45 (45.9%) | 40 (53.3%) | 85 (49.1%) |
Female | 53 (54.1%) | 35 (46.7%) | 88 (50.9%) |
Age (yr), median [Q1, Q3] | 52 [46, 62] | 55 [48.5, 63] | 53 [48, 64.5] |
More tan 55 years, n (%) | |||
< 55 | 58 (59.2%) | 35 (46.7%) | 93 (53.8%) |
≥ 55 | 40 (40.8%) | 40 (53.3%) | 80 (46.2%) |